Cardiac stem cell therapy: Does a newborn infant's heart have infinite potential for stem cell therapy?

Affiliations

¹ Division of Pediatric Cardiothoracic Surgery, Department of Surgery, University of California, San Francisco, San Francisco, Calif. Electronic address: Shunji.sano@ucsf.edu.
² Division of Pediatric Cardiothoracic Surgery, Department of Surgery, University of California, San Francisco, San Francisco, Calif.
³ Department of Hygiene, Kawasaki Medical University, Okayama, Japan.

Free article

Editorial

Shunji Sano et al. J Thorac Cardiovasc Surg. 2022 Jan.

Free article

. 2022 Jan;163(1):242-247.

doi: 10.1016/j.jtcvs.2020.07.124. Epub 2020 Sep 14.

¹ Division of Pediatric Cardiothoracic Surgery, Department of Surgery, University of California, San Francisco, San Francisco, Calif. Electronic address: Shunji.sano@ucsf.edu.
² Division of Pediatric Cardiothoracic Surgery, Department of Surgery, University of California, San Francisco, San Francisco, Calif.
³ Department of Hygiene, Kawasaki Medical University, Okayama, Japan.

No abstract available

Keywords: cardiac progenitor cells; cardiac stem cell therapy; cardiosphere-derived cells; hypoplastic left heart syndrome; single ventricle.

Comment in

Commentary: Neonatal applications of cardiac cell therapy: It's good to be young!
Ryan CT, Rosengart TK. Ryan CT, et al. J Thorac Cardiovasc Surg. 2022 Jan;163(1):248-249. doi: 10.1016/j.jtcvs.2020.09.107. Epub 2020 Oct 7. J Thorac Cardiovasc Surg. 2022. PMID: 33097214 Free PMC article. No abstract available.
Commentary: Defining the role of stem cell therapy in neonatal cardiac regeneration.
Burkhart HM, Qureshi MY. Burkhart HM, et al. J Thorac Cardiovasc Surg. 2022 Jan;163(1):249-250. doi: 10.1016/j.jtcvs.2020.09.013. Epub 2020 Sep 10. J Thorac Cardiovasc Surg. 2022. PMID: 33618871 No abstract available.